Keith Foster

4.4k total citations · 1 hit paper
68 papers, 3.3k citations indexed

About

Keith Foster is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Keith Foster has authored 68 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Neurology, 21 papers in Molecular Biology and 17 papers in Cellular and Molecular Neuroscience. Recurrent topics in Keith Foster's work include Botulinum Toxin and Related Neurological Disorders (35 papers), Neurological disorders and treatments (21 papers) and Hereditary Neurological Disorders (10 papers). Keith Foster is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (35 papers), Neurological disorders and treatments (21 papers) and Hereditary Neurological Disorders (10 papers). Keith Foster collaborates with scholars based in United Kingdom, United States and France. Keith Foster's co-authors include John R. Purkiss, Rolf Pendall, Margaret Cowell, M.J. Welch, Clifford C. Shone, Alain Woda, Marie‐Agnès Peyron, Patrick Foran, J. Oliver Dolly and John A. Chaddock and has published in prestigious journals such as Journal of Biological Chemistry, Applied and Environmental Microbiology and Biochemistry.

In The Last Decade

Keith Foster

67 papers receiving 3.1k citations

Hit Papers

Resilience and regions: building understanding of the met... 2009 2026 2014 2020 2009 100 200 300 400 500

Peers

Keith Foster
John M. Wells United States
Stephanie Dickinson United States
Jon Christensen United States
Elijah W. Stommel United States
William J. Price United States
Keith Foster
Citations per year, relative to Keith Foster Keith Foster (= 1×) peers Katherine R. Smith

Countries citing papers authored by Keith Foster

Since Specialization
Citations

This map shows the geographic impact of Keith Foster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Foster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Foster more than expected).

Fields of papers citing papers by Keith Foster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Foster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Foster. The network helps show where Keith Foster may publish in the future.

Co-authorship network of co-authors of Keith Foster

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Foster. A scholar is included among the top collaborators of Keith Foster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Foster. Keith Foster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tay, Felicia P., Omar Loss, Laurent Pons, et al.. (2024). Botulinum toxin intoxication requires retrograde transport and membrane translocation at the ER in RenVM neurons. eLife. 12. 1 indexed citations
2.
Lin, Kevin, Laine Goudy, Joshua J. Pak, et al.. (2023). CRISPR-Based Epigenome Editing and Genome Wide Screening Define Mediators of Chemotherapy Response in Glioblastoma. International Journal of Radiation Oncology*Biology*Physics. 117(2). S42–S43. 2 indexed citations
3.
Pretzsch, Hans, Peter Biber, Enno Uhl, et al.. (2017). Climate change accelerates growth of urban trees in metropolises worldwide. Scientific Reports. 7(1). 15403–15403. 160 indexed citations
4.
Foster, Keith. (2009). Engineered toxins: New therapeutics. Toxicon. 54(5). 587–592. 26 indexed citations
5.
Fdez, Elena, Thomas A. Jowitt, Ming-Chuan Wang, et al.. (2008). A Role for Soluble N-Ethylmaleimide-sensitive Factor Attachment Protein Receptor Complex Dimerization during Neurosecretion. Molecular Biology of the Cell. 19(8). 3379–3389. 13 indexed citations
6.
Foster, Keith, Hans Bigalke, & K. Roger Aoki. (2006). Botulinum neurotoxin — from laboratory to bedside. Neurotoxicity Research. 9(2-3). 133–140. 52 indexed citations
7.
Foster, Keith. (2005). A new wrinkle on pain relief: re-engineering clostridial neurotoxins for analgesics. Drug Discovery Today. 10(8). 563–569. 19 indexed citations
8.
Chaddock, John A., John R. Purkiss, Frances C.G. Alexander, et al.. (2004). Retargeted clostridial endopeptidases: Inhibition of nociceptive neurotransmitter release in vitro, and antinociceptive activity in in vivo models of pain. Movement Disorders. 19(S8). S42–S47. 50 indexed citations
9.
Hall, Yper, et al.. (2004). Novel application of an in vitro technique to the detection and quantification of botulinum neurotoxin antibodies. Journal of Immunological Methods. 288(1-2). 55–60. 20 indexed citations
10.
Duggan, Michael, John A. Chaddock, John R. Purkiss, et al.. (2002). Inhibition of Release of Neurotransmitters from Rat Dorsal Root Ganglia by a Novel Conjugate of a Clostridium botulinumToxin A Endopeptidase Fragment and Erythrina cristagalliLectin. Journal of Biological Chemistry. 277(38). 34846–34852. 93 indexed citations
11.
Purkiss, John R., et al.. (2000). Capsaicin-stimulated release of substance P from cultured dorsal root ganglion neurons: involvement of two distinct mechanisms. Biochemical Pharmacology. 59(11). 1403–1406. 189 indexed citations
12.
Chaddock, John A., John R. Purkiss, Michael Duggan, et al.. (2000). A Conjugate Composed of Nerve Growth Factor Coupled to a Non-toxic Derivative ofClostridium botulinumNeurotoxin Type A can Inhibit Neurotransmitter Releasein Vitro. Growth Factors. 18(2). 147–155. 39 indexed citations
13.
Wictome, Matthew, et al.. (1999). Development of in vitro assays for the detection of botulinum toxins in foods. FEMS Immunology & Medical Microbiology. 24(3). 319–323. 38 indexed citations
14.
Boyd, Robert S., Michael Duggan, Clifford C. Shone, & Keith Foster. (1995). The Effect of Botulinum Neurotoxins on the Release of Insulin from the Insulinoma Cell Lines HIT-15 and RINm5F. Journal of Biological Chemistry. 270(31). 18216–18218. 50 indexed citations
15.
Foster, Keith, et al.. (1993). Stimulation of phospholipase-D in Epstein Barr virus-transformed human B-cells. Biochemical Society Transactions. 21(3). 291S–291S. 1 indexed citations
16.
Foster, Keith, et al.. (1992). Effect of Rb+ on cromakalim-induced relaxation and ion fluxes in guinea pig trachea. European Journal of Pharmacology. 222(1). 143–151. 6 indexed citations
17.
Buckle, Derek R., J R Arch, C. Edge, et al.. (1991). Synthesis and smooth muscle relaxant activity of a new series of potassium channel activators: 3-amido-1,1-dimethylindan-2-ols. Journal of Medicinal Chemistry. 34(3). 919–926. 23 indexed citations
18.
Arch, J R, Derek R. Buckle, Cynthia Carey, et al.. (1991). Relaxant activity of 6-cyano-2,2-dimethyl-2H-1-benzopyran-4-carboxamides and -thiocarboxamides and their analogs in guinea pig trachealis. Journal of Medicinal Chemistry. 34(8). 2588–2594. 36 indexed citations
19.
Blank, Jonathan L., Keith Foster, & J. N. Hawthorne. (1991). Purification, Properties, and Phosphorylation by Protein Kinase C of Two Phosphoinositidase C Isozymes from Rat Brain. Journal of Neurochemistry. 57(1). 15–21. 9 indexed citations
20.
Buckle, Derek R., Keith Foster, John F. Taylor, et al.. (1987). Novel 1H-benzimidazol-4-ols with potent 5-lipoxygenase inhibitory activity. Journal of Medicinal Chemistry. 30(12). 2216–2221. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026